These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6965594)

  • 1. Use of venom coagglutinin and lyophilized platelets in testing for platelet-aggregating von Willebrand factor.
    Brinkhous KM; Read MS
    Blood; 1980 Mar; 55(3):517-20. PubMed ID: 6965594
    [No Abstract]   [Full Text] [Related]  

  • 2. Venom coagglutinin: an activator of platelet aggregation dependent on von Willebrand factor.
    Read MS; Shermer RW; Brinkhous KM
    Proc Natl Acad Sci U S A; 1978 Sep; 75(9):4514-8. PubMed ID: 309134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiology of platelet-aggregating von Willebrand factor: applications of the venom coagglutinin vWF assay.
    Brinkhous KM; Read MS; Reddick RL; Griggs TR
    Ann N Y Acad Sci; 1981; 370():191-204. PubMed ID: 7023318
    [No Abstract]   [Full Text] [Related]  

  • 4. The influence of 2-mercaptoethanol on von Willebrand factor and bovine platelet aggregating factor.
    Suzuki K; Nishioka J; Hashimoto S
    Thromb Res; 1980 Feb 1-15; 17(3-4):443-52. PubMed ID: 6966083
    [No Abstract]   [Full Text] [Related]  

  • 5. Interaction of ristocetin and von Willebrand factor.
    Jenkins CS; Meyer D; Larrieu MJ
    Thromb Haemost; 1976 Jun; 35(3):752-3. PubMed ID: 1086517
    [No Abstract]   [Full Text] [Related]  

  • 6. Support of ristocetin-induced platelet aggregation by procoagulant-inactive and plasmin-cleaved forms of human factor VIII/von Willebrand factor.
    Andersen JC; Switzer ME; McKee PA
    Blood; 1980 Jan; 55(1):101-8. PubMed ID: 6444272
    [No Abstract]   [Full Text] [Related]  

  • 7. Preservation of platelet receptors for platelet aggregating factor/von Willebrand factor by air drying, freezing, or lyophilization: new stable platelet preparations for von Willebrand factor assays.
    Brinkhous KM; Read MS
    Thromb Res; 1978 Oct; 13(4):591-7. PubMed ID: 311530
    [No Abstract]   [Full Text] [Related]  

  • 8. Interaction of the cysteine-rich domain of snake venom metalloproteinases with the A1 domain of von Willebrand factor promotes site-specific proteolysis of von Willebrand factor and inhibition of von Willebrand factor-mediated platelet aggregation.
    Serrano SMT; Wang D; Shannon JD; Pinto AFM; Polanowska-Grabowska RK; Fox JW
    FEBS J; 2007 Jul; 274(14):3611-3621. PubMed ID: 17578514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphological studies of platelet aggregates induced by human von Willebrand factor in platelet-type von Willebrand's disease.
    Takahashi H; Hattori A; Nagayama R; Hanano M; Fuse I; Takizawa S; Takeshige T; Shibata A
    Thromb Res; 1985 May; 38(4):433-8. PubMed ID: 3874446
    [No Abstract]   [Full Text] [Related]  

  • 10. Agglutination of platelet-type von Willebrand's disease platelets by bovine von Willebrand factor.
    Takahashi H; Shibata A
    Thromb Haemost; 1985 Apr; 53(2):204-7. PubMed ID: 2992113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vancomycin as well as ristocetin facilitates von Willebrand factor binding to platelets.
    Suzuki K; Nishioka J; Hashimoto S
    Thromb Res; 1980 Jul 1-15; 19(1-2):287-92. PubMed ID: 6969463
    [No Abstract]   [Full Text] [Related]  

  • 12. Von Willebrand syndrome induced by a Bothrops venom factor: bioassay for venom coagglutinin.
    Brinkhous KM; Barnes DS; Potter JY; Read MS
    Proc Natl Acad Sci U S A; 1981 May; 78(5):3230-4. PubMed ID: 6789334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the quantitative ristocetin von Willebrand factor assay by using fresh and fixed platelets.
    Kelton JG; Bishop J; Carter CJ; Hirsh J
    Thromb Res; 1980 May 1-15; 18(3-4):477-83. PubMed ID: 6968105
    [No Abstract]   [Full Text] [Related]  

  • 14. Venom coagglutinin for detection of von Willebrand factor activity in animal plasmas.
    Read MS; Potter JY; Brinkhous KM
    J Lab Clin Med; 1983 Jan; 101(1):74-82. PubMed ID: 6600265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of frozen thrombocytes for the determination of von willebrand factor with the aid of ristocetin].
    Caduff T; Straub PW
    Schweiz Med Wochenschr; 1979 Mar; 109(11):399-402. PubMed ID: 34214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botrocetin (venom coagglutinin): reaction with a broad spectrum of multimeric forms of factor VIII macromolecular complex.
    Brinkhous KM; Read MS; Fricke WA; Wagner RH
    Proc Natl Acad Sci U S A; 1983 Mar; 80(5):1463-6. PubMed ID: 6402781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heightened interaction between platelets and factor VIII/von Willebrand factor in a new subtype of von Willebrand's disease.
    Ruggeri ZM; Pareti FI; Mannucci PM; Ciavarella N; Zimmerman TS
    N Engl J Med; 1980 May; 302(19):1047-51. PubMed ID: 6767976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ristocetin in the diagnosis of von willebrand's disease: a comparison of rate and percent of aggregation with levels of the plasma factor(s) necessary for ristocetin aggregation.
    Dowling SV; Muntz RH; D'Souza S; Ekert H
    Thromb Diath Haemorrh; 1975 Nov; 34(2):465-74. PubMed ID: 1081746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new von Willebrand variant (type I, New York): increased ristocetin-induced platelet aggregation and plasma von Willebrand factor containing the full range of multimers.
    Weiss HJ; Sussman II
    Blood; 1986 Jul; 68(1):149-56. PubMed ID: 3487353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agglutination of formalin-fixed, platelet-type von Willebrand's disease platelets by human von Willebrand factor.
    Takahashi H; Shibata A
    Thromb Haemost; 1984 Dec; 52(3):267-70. PubMed ID: 6241752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.